Analysts/Institutional Investor Meet/Con. Call Updates

2nd November, 2026 To, To, The Manager, The Manager, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 533573 NSE Symbol: APLLTD Dear Sir/Madam, Sub: Updated link for the Post Results Conference Call With reference to our earlier intimation regarding Post Results Conference Call for analysts / institutional investors scheduled on Wednesday, 4th November, 2026, at 5:00 P.M. the updated link of the said conference call is as under: Diamond Pass Registration Conference dial-in number remains unchanged as under: Universal Access Number +91 22 6280 1411 +91 22 7115 8312 India Toll Free Number 1 800 120 1221 International Toll Free USA 1866 746 2133 Number UK 080 810 11573 Singapore 800 101 2045 Hong Kong 800 96 4448 For further information please contact Ms. Isha Lamba (Phone: +91 22-66951652; Email: isha.lamba@alembic.co.in) Kindly take note of the same. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Chirag K. Shukla Company Secretary ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123